14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AYLA
Delisted

Ayala Pharmaceuticals Inc Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.504
+0 (+0%)
At Close: Apr 17, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Oct 18, 2023 Buy 0 Martell Bridget A
Oct 18, 2023 Buy 0 Orbach Pini
Oct 18, 2023 Buy 0 Golan Roy
Jan 19, 2023 Sell 2 991 473 Amoon Growth Fund Limited Partnership Common Stock
Jan 19, 2023 Sell 12 500 Sidransky David Stock Option (right to buy)
Jan 19, 2023 Sell 31 950 Maimon Yossi Stock Option (right to buy)
Jan 19, 2023 Sell 6 250 Spiegel Robert J. Stock Option (right to buy)
Jan 19, 2023 Sell 31 950 Gordon Gary B. Stock Option (right to buy)
Jan 19, 2023 Sell 6 250 Goldberg Murray A Stock Option (right to buy)
Jan 19, 2023 Sell 6 250 Bisker-leib Vered Stock Option (right to buy)
Jan 19, 2023 Sell 127 800 Mamluk Roni Stock Option (right to buy)
Jun 13, 2022 Buy 6 250 Goldberg Murray A Stock Option (Right to Buy)
Jun 13, 2022 Buy 6 250 Goldberg Murray A Stock Option (Right to Buy)
Jun 13, 2022 Buy 12 500 Sidransky David Stock Option (Right to Buy)
Jun 13, 2022 Buy 6 250 Spiegel Robert J. Stock Option (Right to Buy)
Jun 13, 2022 Buy 6 250 Bisker-leib Vered Stock Option (Right to Buy)
May 16, 2022 Buy 50 000 Maimon Yossi Common Stock
May 16, 2022 Buy 50 000 Gordon Gary B. Common Stock
May 16, 2022 Buy 120 000 Mamluk Roni Common Stock
Jan 03, 2022 Buy 127 800 Mamluk Roni Stock Option
Jan 03, 2022 Buy 31 950 Gordon Gary B. Stock Option
Jan 03, 2022 Buy 31 950 Maimon Yossi Stock Option
Jun 10, 2021 Buy 6 250 Bisker-leib Vered Stock Option (Right to Buy)
Jun 10, 2021 Buy 6 250 Spiegel Robert J. Stock Option (Right to Buy)
Jun 10, 2021 Buy 12 500 Sidransky David Stock Option (Right to Buy)
Jun 10, 2021 Buy 6 250 Goldberg Murray A Stock Option (Right to Buy)
Jun 10, 2021 Buy 6 250 Sone Todd Stock Option (Right to Buy)
Feb 24, 2021 Sell 3 000 Gordon Gary B. Stock Option
Feb 24, 2021 Buy 3 000 Gordon Gary B. Common Stock
Feb 24, 2021 Sell 3 000 Gordon Gary B. Common Stock
Feb 24, 2021 Sell 10 800 Mamluk Roni Common Stock
Feb 23, 2021 Sell 7 126 Mamluk Roni Common Stock
Feb 22, 2021 Sell 15 200 Mamluk Roni Common Stock
Jan 21, 2021 Sell 1 406 Mamluk Roni Common Stock
Jan 20, 2021 Sell 19 466 Mamluk Roni Common Stock
Jan 20, 2021 Sell 3 000 Gordon Gary B. Stock Option
Jan 20, 2021 Buy 3 000 Gordon Gary B. Common Stock
Jan 20, 2021 Sell 3 000 Gordon Gary B. Common Stock
Jan 04, 2021 Buy 8 520 Maimon Yossi Common Stock
Jan 04, 2021 Buy 19 170 Gordon Gary B. Stock Option
Jan 04, 2021 Buy 19 170 Maimon Yossi Stock Option
Jan 04, 2021 Buy 8 520 Gordon Gary B. Common Stock
Jan 04, 2021 Buy 34 080 Mamluk Roni Common Stock
Jan 04, 2021 Buy 76 680 Mamluk Roni Stock Option
Dec 23, 2020 Buy 4 Sidransky David Common Stock
Sep 14, 2020 Buy 1 Sidransky David Common Stock
Sep 11, 2020 Buy 10 Sidransky David Common Stock
Aug 18, 2020 Buy 8 750 Bisker-leib Vered Stock Option (Right to Buy)
Aug 18, 2020 Buy 0 Bisker-leib Vered
Aug 14, 2020 Buy 5 Sidransky David Common Stock
Jul 17, 2020 Buy 4 Sidransky David Common Stock
Jul 07, 2020 Buy 1 Sidransky David Common Stock
May 12, 2020 Buy 25 Sidransky David Common Stock
May 12, 2020 Buy 0 Harel Insurance Co Ltd
May 12, 2020 Buy 500 000 Harel Insurance Co Ltd Common Stock, par value $0.01 per share
May 12, 2020 Buy 50 000 Harel Insurance Co Ltd Common Stock, par value $0.01 per share
May 12, 2020 Buy 211 757 Harel Insurance Co Ltd Common Stock, par value $0.01 per share
May 12, 2020 Buy 307 692 Harel Insurance Co Ltd Common Stock, par value $0.01 per share
May 12, 2020 Sell 307 692 Harel Insurance Co Ltd Series A Preferred Stock, par value $0.01 per share
May 12, 2020 Sell 211 757 Harel Insurance Co Ltd Series B Preferred Stock, par value $0.01 per share
May 12, 2020 Buy 225 000 Israel Biotech Fund I, L.p. Common Stock
May 12, 2020 Buy 211 757 Israel Biotech Fund I, L.p. Common Stock
May 12, 2020 Buy 369 231 Israel Biotech Fund I, L.p. Common Stock
May 12, 2020 Sell 738 462 Israel Biotech Fund I, L.p. Series A Preferred Stock
May 12, 2020 Sell 423 514 Israel Biotech Fund I, L.p. Series B Preferred Stock
May 12, 2020 Buy 800 000 Amoon 2 Fund Limited Partnership Common Stock
May 12, 2020 Buy 508 924 Amoon 2 Fund Limited Partnership Common Stock
May 12, 2020 Buy 369 231 Amoon 2 Fund Limited Partnership Common Stock
May 12, 2020 Sell 738 462 Amoon 2 Fund Limited Partnership Series A Preferred Stock
May 12, 2020 Sell 1 017 848 Amoon 2 Fund Limited Partnership Series B Preferred Stock
May 08, 2020 Buy 200 Sidransky David Common Stock
May 07, 2020 Buy 11 352 Maimon Yossi Common Stock
May 07, 2020 Buy 47 299 Mamluk Roni Common Stock
May 07, 2020 Buy 47 299 Mamluk Roni Stock Option
May 07, 2020 Buy 0 Harel Insurance Co Ltd Common Stock, par value $0.01 per share
May 07, 2020 Buy 307 692 Harel Insurance Co Ltd Series A Preferred Stock, par value $0.01 per share
May 07, 2020 Buy 211 757 Harel Insurance Co Ltd Series B Preferred Stock, par value $0.01 per share
May 07, 2020 Buy 70 500 Maimon Yossi Stock Option
May 07, 2020 Buy 9 460 Maimon Yossi Stock Option
May 07, 2020 Buy 95 000 Gordon Gary B. Stock Option
May 07, 2020 Buy 0 Sidransky David
May 07, 2020 Buy 0 Mamluk Roni Common Stock
May 07, 2020 Buy 70 665 Mamluk Roni Stock Option
May 07, 2020 Buy 0 Israel Biotech Fund I, L.p. Common Stock
May 07, 2020 Buy 369 231 Israel Biotech Fund I, L.p. Series A Preferred Stock
May 07, 2020 Buy 211 757 Israel Biotech Fund I, L.p. Series B Preferred Stock
May 07, 2020 Buy 0 Sone Todd
May 07, 2020 Buy 0 Amoon 2 Fund Limited Partnership Common Stock
May 07, 2020 Buy 369 231 Amoon 2 Fund Limited Partnership Series A Preferred Stock
May 07, 2020 Buy 508 924 Amoon 2 Fund Limited Partnership Series B Preferred Stock
May 07, 2020 Buy 17 500 Spiegel Robert J. Stock Option
May 07, 2020 Buy 12 500 Spiegel Robert J. Stock Option
May 07, 2020 Buy 17 500 Goldberg Murray A Stock Option
May 07, 2020 Buy 12 500 Goldberg Murray A Stock Option
JSON CSV
INSIDER POWER
-72.135
Last 94 transactions
Buy: 6 611 599 | Sell: 6 718 156 (Shares)

Based on the 94 latest insides trades, we have calculated the insider power to be negative at a ratio of -72.135.

In total, the insiders bought 6 611 599 and sold 6 718 156 AYLA shares in the last 94 trades.

Click to get the best stock tips daily for free!

About Ayala Pharmaceuticals Inc

Ayala Pharmaceuticals Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-... AYLA Profile

Golden Star

Ticker Date Change Price
HRB Apr 29 1.00% $47.23
LYG Apr 29 0.391% $2.56
ORA Apr 29 1.95% $64.48
ETSY Apr 26 3.43% $67.43
DHT Apr 24 0.98% $11.28
LPLA Apr 19 1.10% $262.59
MLI Apr 19 7.29% $52.28
PFLT Apr 18 1.33% $11.25
DOOR Apr 18 0.94% $131.39
OCSL Apr 17 0.360% $19.43
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT